These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 2663831
1. Nonmalignant complications of therapy for Hodgkin's disease. Hohl RJ, Schilsky RL. Hematol Oncol Clin North Am; 1989 Jun; 3(2):331-43. PubMed ID: 2663831 [Abstract] [Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study. Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C. Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578 [Abstract] [Full Text] [Related]
3. Late complications of Hodgkin's disease management. Young RC, Bookman MA, Longo DL. J Natl Cancer Inst Monogr; 1990 Sep; (10):55-60. PubMed ID: 2189477 [Abstract] [Full Text] [Related]
4. Late complications of therapy of Hodgkin's disease: prevention and management. Ng AK, Mauch PM. Curr Hematol Rep; 2004 Jan; 3(1):27-33. PubMed ID: 14695846 [Abstract] [Full Text] [Related]
5. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CN. Cancer J Sci Am; 1995 Jan; 1(1):33-42. PubMed ID: 9166452 [Abstract] [Full Text] [Related]
6. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease. Viviani S, Bonfante V, Santoro A, Zanini M, Devizzi L, Di Russo AD, Soncini F, Villani F, Ragni G, Valagussa P, Bonadonna G. Cancer J Sci Am; 1999 Jan; 5(5):275-82. PubMed ID: 10526668 [Abstract] [Full Text] [Related]
7. Hodgkin's disease in children. Pao WJ, Kun LE. Hematol Oncol Clin North Am; 1989 Jun; 3(2):345-65. PubMed ID: 2663832 [Abstract] [Full Text] [Related]
8. Complications of treatment of Hodgkin's disease in children. Donaldson SS, Kaplan HS. Cancer Treat Rep; 1982 Apr; 66(4):977-89. PubMed ID: 7074658 [Abstract] [Full Text] [Related]
9. Concomitant illness in patients treated for Hodgkin's disease. Bookman MA, Longo DL. Cancer Treat Rev; 1986 Jun; 13(2):77-111. PubMed ID: 3527412 [No Abstract] [Full Text] [Related]
10. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease. Villani F, Busia A, Villani M, Laffranchi A, Viviani S, Bonfante V. Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235 [Abstract] [Full Text] [Related]
11. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD. Enrici RM, Anselmo AP, Donato V, Falchetto Osti M, Santoro M, Tombolini V, Mandelli F. Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040 [Abstract] [Full Text] [Related]
12. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, Prosnitz LR. J Clin Oncol; 2006 Feb 01; 24(4):605-11. PubMed ID: 16446333 [Abstract] [Full Text] [Related]
13. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A, German Hodgkin's Lymphoma Study Group. J Clin Oncol; 2005 Oct 20; 23(30):7555-64. PubMed ID: 16234521 [Abstract] [Full Text] [Related]
14. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up. Brusamolino E, Baio A, Orlandi E, Arcaini L, Passamonti F, Griva V, Casagrande W, Pascutto C, Franchini P, Lazzarino M. Clin Cancer Res; 2006 Nov 01; 12(21):6487-93. PubMed ID: 17085663 [Abstract] [Full Text] [Related]
15. Analysis of the risk of solid tumor following Hodgkin's disease. Maurizi Enrici R, Anselmo AP, Osti MF, Santoro M, Tombolini V, Mandelli F, Biagini C. Haematologica; 1997 Nov 01; 82(1):57-63. PubMed ID: 9107084 [Abstract] [Full Text] [Related]
16. [Late complications after treatment of Hodgkin's disease]. Lund MB, Kongerud J, Boe J, Ihlen H, Forfang K, Abrahamsen AF, Nome O. Tidsskr Nor Laegeforen; 1999 Mar 10; 119(7):933-7. PubMed ID: 10210953 [Abstract] [Full Text] [Related]
17. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation. Chow LM, Nathan PC, Hodgson DC, Jenkin D, Weitzman S, Grant RM, Manson D, Bross A, Doyle JJ, Danjoux C, Greenberg ML. J Clin Oncol; 2006 Dec 20; 24(36):5735-41. PubMed ID: 17179107 [Abstract] [Full Text] [Related]
18. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Salloum E, Doria R, Farber LR, Roberts KB, Cooper DL. Cancer J Sci Am; 1995 Dec 20; 1(4):267-73. PubMed ID: 9166487 [Abstract] [Full Text] [Related]
19. Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. Kuten A, Lubochitski R, Fishman G, Dale J, Stein ME. J Surg Oncol; 1996 Apr 20; 61(4):281-3. PubMed ID: 8627999 [Abstract] [Full Text] [Related]
20. Late effects of Hodgkin's disease and its treatment. Ng AK, Mauch PM. Cancer J; 2009 Apr 20; 15(2):164-8. PubMed ID: 19390314 [Abstract] [Full Text] [Related] Page: [Next] [New Search]